In the present study, serum CCL18 levels were found to be significantly high in patients with SCCHN compared to precancerous lesions of SCCHN patients and healthy controls, and its levels correlated with tumour classification, clinical stage, lymph node metastasis and histological grade in SCCHN patients. This evidence concerns the gene CCL18 and metastatic malignant neoplasm in the lymph nodes.